- Condition: Healthy
Interventions: Drug: Naloxone; Drug: Delta-9-THC; Drug: Placebo
Sponsors: Yale University; Yale University
Recruiting - verified May 2012 - Condition: Low Back Pain
Interventions: Drug: Methadone; Drug: Buprenorphine/naloxone
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo
Recruiting - verified March 2012 - Condition: Opioid Dependence
Interventions: Drug: Aprepitant; Drug: Placebo pill
Sponsors: New York University; New York University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Parkinson's Disease With Severe Pain
Interventions: Drug: Oxycodone/Naloxone Prolonged Release tablets; Drug: Placebo
Sponsors: Mundipharma Research GmbH & Co KG; Mundipharma Research GmbH & Co KG
Recruiting - verified February 2012 - Condition: Low Back Pain
Interventions: Drug: Oxycodone/Naloxone controlled-release; Drug: Oxycodone HCl controlled-release; Drug: Placebo
Sponsors: Purdue Pharma LP; Purdue Pharma LP
Recruiting - verified May 2012 - Condition: Low Back Pain
Interventions: Drug: Oxycodone/Naloxone controlled-release; Drug: Oxycodone HCl controlled-release; Drug: Placebo
Sponsors: Purdue Pharma LP; Purdue Pharma LP
Recruiting - verified May 2012 - Conditions: Pain; Constipation
Interventions: Drug: oxycodone/naloxone prolonged release (OXN PR) tablets; Drug: oxycodone prolonged release (OxyPR) tablets
Sponsors: Mundipharma Research GmbH & Co KG; Mundipharma Research GmbH & Co KG
Recruiting - verified May 2012 - Condition: Cocaine Dependence
Interventions: Drug: Buprenorphine + Naltrexone; Drug: Placebo + Naltrexone
Sponsors: University of California, Los Angeles; Walter Ling; National Institute on Drug Abuse (NIDA); The EMMES Corporation
Recruiting - verified February 2012 - Conditions: Pain, Postoperative; Postoperative Nausea and Vomiting; Scoliosis
Interventions: Drug: Naloxone; Drug: Naloxone
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City
Recruiting - verified February 2012 - Conditions: Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome; Opiate Addiction; Drug Dependence
Intervention: Drug: Buprenorphine/naloxone
Sponsors: Yale University; Yale University; George Mason University; Howard University
Recruiting - verified April 2012 - Condition: Low Back Pain
Interventions: Drug: Oxycodone/Naloxone Controlled-release; Drug: Placebo
Sponsors: Purdue Pharma LP; Purdue Pharma LP
Recruiting - verified February 2012 - Condition: Cancer
Intervention: Drug: oxycodone and naloxone
Sponsors: Mundipharma; Mundipharma
Recruiting - verified April 2012 - Conditions: Interstitial Cystitis; Painful Bladder Syndrome; Pain
Interventions: Drug: Oxycodone naloxone prolonged release tablets; Drug: Placebo tablets
Sponsors: Mundipharma Research GmbH & Co KG; Mundipharma Research GmbH & Co KG
Recruiting - verified February 2012 - Conditions: Opioid Related Disorders; Opioid Dependence; Opioid Addiction
Interventions: Drug: Buprenorphine/naloxone; Drug: Clonidine; Drug: Tramadol ER
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Opiate Dependence
Intervention: Drug: Methadone, naloxone
Sponsors: Kuopio University Hospital; Kuopio University Hospital
Not yet recruiting - verified March 2012 - Conditions: Postoperative Pain; Opioid Induced Constipation
Interventions: Drug: naloxone; Drug: oxycodone
Sponsors: Oslo University Hospital; Ullevaal University Hospital; Mundipharma AB
Recruiting - verified April 2010 - Condition: Pruritus
Interventions: Drug: Naloxone; Drug: Saline/Morphine
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Opiate Addiction
Interventions: Drug: Buprenorphine/naloxone; Drug: Naltrexone
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo
Recruiting - verified February 2011 - Conditions: Diabetes Mellitus; Hypoglycemia; Autonomic Failure
Interventions: Drug: naloxone; Dietary Supplement: fructose; Behavioral: exercise
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Conditions: Opiate Dependence; Chronic Pain
Interventions: Behavioral: CBT; Drug: Buprenorphine; Other: Educational Counseling; Other: Physician Management
Sponsors: Yale University; Yale University
Recruiting - verified May 2012 - Condition: Opiate Dependence
Interventions: Behavioral: Behavioral: Buprenorphine/naloxone maintenance (Mtn); Behavioral: Behavioral: Buprenorphine/naloxone detoxification (Dtx)
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011
 |
Join Clinical trials for Naloxone |
